BioNTech will supply pumitamig, a PD-L1/VEGF-A bispecific antibody co-developed with Bristol Myers Squibb, while Boehringer Ingelheim will act as the regulatory sponsor of a Phase Ib/II study
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
Workshop on ECG interpretation also marks launch of “Handbook on ECGs – Volume 2”
Paves the way for next-gen ultra-precise gas sensing
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
On-site medical room brings preventive care, routine consultations, and diagnostics closer to residents
The solution integrates key molecular cloning methods—including Golden Gate, Gibson assembly, and restriction/ligation—alongside primer design, Sanger sequencing analysis, and protein translation in a single application
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
Subscribe To Our Newsletter & Stay Updated
